Skip to content

Clinical trials

Scleroderma, Diffuse trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Diffuse Country / region: United States Clear all

151 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20024
20031
20041
20053
20066
20073
20083
20096
20106
20114
20123
20137
20146
20156
20168
20176
20187
20196
20206
202110
20224
20235
202411
202511
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed74
Terminated25
Recruiting21
Active, not recruiting10
Unknown status8
Withdrawn7
Not yet recruiting3
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Michigan14
Johns Hopkins University8
Bristol-Myers Squibb5
MediQuest Therapeutics5
Boston University4
Duke University4
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)4
Georgetown University3
Novartis Pharmaceuticals3
United Therapeutics3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Diffuse151
Scleroderma, Systemic71
Autoimmune Diseases20
Lung Diseases, Interstitial18
Arthritis, Rheumatoid17
Lupus Erythematosus, Systemic15
Raynaud Disease15
Myositis14
Sjogren's Syndrome13
Connective Tissue Diseases9

Trials

Showing 1 to 25 of 151. Each trial links to its page on Pharma Observatory.

51 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.